SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

78,954.76 373.76
( 0.48%)

Global Indices

Nasdaq

54,370.92 264.04
(0.49%)

Dow Jones

7,742.03 -15.49
(-0.20%)

Hang Seng

65,663.80 -636.64
(-0.96%)

Nikkei 225

10,894.52 15.14
(0.14%)

Forex

USD-INR

95.23 -0.06
(-0.07%)

EUR-INR

109.68 -0.11
(-0.10%)

GBP-INR

127.98 -0.19
(-0.15%)

JPY-INR

0.60 0.00
(-0.60%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Bal Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524824

INE083D01012

65.3864135

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BALPHARMA

21.01

141.85

EPS(TTM)

Face Value()

Div & Yield %

4.24

1.35

Back

Reliance Industries consolidated net profit declines 22.40% in the June 2026 quarter

Jul 18,2026

Net profit of Reliance Industries declined 22.40% to Rs 20946.00 crore in the quarter ended June 2026 as against Rs 26994.00 crore during the previous quarter ended June 2025. Sales rose 27.02% to Rs 309468.00 crore in the quarter ended June 2026 as against Rs 243632.00 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	309468.00	243632.00	27
OPM %	15.35	17.61	-
PBDT	45730.00	42064.00	9
PBT	30630.00	28222.00	9
NP	20946.00	26994.00	-22

78,954.76 373.76 ( 0.48%)

54,370.92 264.04 (0.49%)

7,742.03 -15.49 (-0.20%)

65,663.80 -636.64 (-0.96%)

10,894.52 15.14 (0.14%)

95.23 -0.06 (-0.07%)

109.68 -0.11 (-0.10%)

127.98 -0.19 (-0.15%)

0.60 0.00 (-0.60%)